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Amblyopia: past, present and future
Amblyopia affects around 2–2.5% of Western populations.
Undetected refractive error aside, it is the most common
form of childhood visual impairment that front-line eye
care professionals encounter. In fact, it has recently been
shown that management of amblyopia accounts for around
75% of all eye appointments in the NHS paediatric eye
service.1 This fact, combined with a national screening pro-
gramme to detect the condition early, suggests that ambly-
opia remains a major public health concern and
considerable healthcare resources are devoted to detecting
and treating it.
If left untreated, amblyopia produces a range of func-
tional deficits that include poor monocular visual acuity,
reduced contrast sensitivity, positional uncertainty, marked
distortions of visual space and elevated levels of visual
crowding in the amblyopic eye. Binocular function is also
compromised; subjects commonly display poor oculomo-
tor control (e.g. fixation stability, saccade accuracy and
timing, fusional vergence), suppression of all or part of the
visual input from the affected eye and reduced stereoacuity.
More recently, studies have started to quantify how the
presence of amblyopia (or its treatment) impact on educa-
tional attainment, future career opportunities, self-esteem
and quality of life. These studies reveal the practical and
emotional impact of amblyopia and provide additional evi-
dence in support of the need to develop effective treatment.
Given the scale of the problem and the obvious func-
tional and social costs of not treating the condition, it
seems timely to review the body of work devoted to this
topic that has appeared in Ophthalmic and Physiological
Optics over the last decade or so. This period has seen
intense debate around whether amblyopia should be trea-
ted, the quality of evidence needed to justify screening and
treatment, and the development of some exciting new treat-
ment strategies. All of these important issues are covered in
this special virtual issue on amblyopia.
The first paper in the collection2 asks a simple but
important question. What are the principal causes of
reduced visual acuity in children? Using a school-based
paediatric survey, the authors show that in children in
China (age 3–6 years), around two-thirds have reduced
visual acuity from uncorrected refractive error and the
remaining third from amblyopia. These figures are also
likely to represent those of Asian populations in other
countries.
Animal models of amblyopia have been instrumental in
revealing the underlying pathophysiology of the condition.
Studies in both cat and monkey have shown that even brief
periods of abnormal visual input, introduced early in devel-
opment, have dramatic consequences on the structure and
function of cortical visual pathways. Specifically, sensitivity
to high spatial frequencies is reduced and binocular
responses are abnormal. These studies have placed the pri-
mary site of the abnormality at the level of the visual cortex.
However, many people have argued that visual deprivation,
which is usually introduced via lid suture, is not a particu-
larly representative model of the human condition. In
humans, amblyopia is much more frequently associated
with unequal amounts of refractive error or strabismus.
This has led some to speculate that the visual deficit associ-
ated with naturally occurring human amblyopia may reside
at a different location in the visual pathway. The next two
papers deal with this issue. Debert et al.3 ask whether there
are important differences in the oculometric parameters in
children with amblyopia and esotropia. They found that
amblyopic eyes are significantly more hyperopic and have
reduced corneal power, greater lens power and shorter vit-
reous chamber depth and axial length compared to fellow
eyes. The degree of refractive error is strongly related to the
axial length/corneal radius ratio and this is similar in fellow
and amblyopic eyes. This suggests that the mechanisms that
govern relative growth of the ocular components are essen-
tially normal in amblyopia. Next, Brown et al.4 examine
neural retinal function to probe whether the primary deficit
in amblyopia resides at the level of the retina. In subjects
with previously identified compromised function at the
level of the lateral geniculate nucleus (established using
functional magnetic resonance imaging), they used
multi-focal ERG, optical coherence tomography and
microperimetry to evaluate responses from the central
visual field. Although they found central deficits in retinal
function, there were no obvious anatomical or structural
problems identified. They speculate that the retinal and
LGN deficits may not be linked. However, previous work in
cats has indicated that early visual deprivation can intro-
duce deficits earlier in the visual pathway.5 The potential
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link between anatomical defects in the retina and the subse-
quent development of amblyopia are explored in more
detail by Barrett et al.6 They discuss a series of studies that
suggest that unidentified organic abnormalities may lie
behind some poor treatment outcomes.
In 1997, Snowden and Stewart-Brown7 produced a sys-
tematic evaluation of childhood screening to detect ambly-
opia. This report has had a considerable impact on the
field. It highlighted the need for more rigorous studies to
support the efficacy of treatment. This is essential to justify
the continued expense of a whole-population screening
programme. The report acted as a catalyst for the develop-
ment of multi-centre randomized controlled trials (RCT)
and a renewed interest in exploring new treatment options
for amblyopia.
In an illuminating exchange, Kulp & Cotter and Connor
& Clarke8 present both sides of the debate around whether
amblyopia treatment is worthwhile. Kulp and Cotter point
out that screening is cost-effective and detects amblyopia at
a point where treatment may be most effective. As a result,
the prevalence of amblyopia is now lower amongst older
children. In support of their viewpoint, they draw on evi-
dence from a series of RCTs, including those from the
influential paediatric eye disease investigator group
(PEDIG), which have provided compelling evidence both
for the effectiveness of treatment and how it might be mod-
ified by clinicians. They conclude that treatment is valuable
and leads to significant gains in quality of life that are expe-
rienced over the remaining lifespan. In contrast, Connor
and Clarke make the point that, if stricter exclusion criteria
are applied to the selection of RCTs (e.g. inclusion of a
matched control group which does not receive treatment),
the treatment gains appear to be smaller. They also high-
light the importance of considering slippage; that is, the
loss of treatment gains over time. This occurs in over 25%
of cases and means that another form of treatment may be
needed to consolidate the gains made from occlusion ther-
apy. Treatment itself, particularly in the case of occlusion,
is associated with some negative consequences. For exam-
ple, skin irritation from the patch, reverse amblyopia (very
rare), psychosocial effects resulting from patch wear and the
fact that the visual capacity of the child is reduced during
treatment. These factors are likely to combine to produce a
low rate of compliance, which has been reported by several
studies. They also question the conclusions drawn from
quality of life studies and suggest that methodological issues
may cloud interpretation and amplify the negative conse-
quences. For example, they make the important point that
the quality of life effects of strabismus and amblyopia need
to be considered separately. This opinion piece highlights a
number of important issues that require further study.
Perhaps one of the key changes to amblyopia treatment
over the last decade has been the realisation that refractive
correction alone may be sufficient to treat amblyopia in a
proportion of cases. Moseley et al.9 present experimental
evidence showing that over a 4–24 week period, significant
gains in visual acuity (0.1–0.5 logMAR) are obtained simply
by providing a spectacle correction alone. This finding has
now established refractive adaptation as an important first-
stage of any treatment strategy. The neural mechanisms
that mediate this improvement remain largely unknown,
particularly in the case of strabismus where the image will
remain on a non-corresponding point in the deviated eye.
In related work, Read et al.10 point out that high levels of
astigmatism need to be corrected as early as possible to
avoid the development of amblyopia. While refractive
adaptation processes are able to compensate for the per-
ceived impact of astigmatism in the short-term, it’s impor-
tant from a developmental perspective that this error is
removed. Optometrists are ideally positioned to measure
and correct childhood refractive error and could in many
cases remove the need for any further treatment.
Another important development in the treatment of
amblyopia has been the decoupling of the timescale over
which anomalous visual inputs exert an influence on
visual function and the time period over which the effects
can be reversed. This has extended the potential treatment
window from childhood into adulthood.11 Although the
results from occlusion therapy indicate that it is most
effective when initiated early, there is some evidence that
it can also improve vision in adults with amblyopia. How-
ever, in older age groups it appears that more active thera-
pies may be a better option. A study by Chen et al.12
compares the effects of patching with those of perceptual
learning in patients with anisometropic amblyopia. The
authors found that visual acuity and contrast sensitivity
improved using both perceptual learning and occlusion in
older children and adults with amblyopia. They also noted
that the rate of improvement was faster for perceptual
learning, which could lead to reduced treatment times.
Following this, Astle et al.13 describe the range of
improvements that can be generated via perceptual learn-
ing in amblyopia and explore how these effects generalise
to other tasks. This again has important implications for
treatment since very selective improvements are unlikely
to be of great benefit to the patient. They also discuss how
the principles of perceptual learning could be incorporated
into video-game formats, paving the way for home-based
therapy that might be better tolerated by patients. Finally,
Evans et al.14 show that not all forms of ‘active therapy’
are equally effective. In a double-masked RCT, intermit-
tent photic stimulation and a control treatment were given
to 30 participants aged 10–57 years. Although improve-
ments were significantly greater for the treatment group,
the effects were restricted to subjects with strabismus and
dissipated completely over the period of a year. The
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authors conclude that perceptual learning may be a more
promising treatment option.
Although amblyopia is manifest as a monocular visual
acuity deficit and traditional treatment approaches target
remediation of this loss, a number of animal studies have
highlighted an important role for binocular co-operation
in recovery. Work by Mitchell & Duffy15 using a depriva-
tion model of amblyopia in cats has revealed three impor-
tant principles for treatment. First, short periods of
binocular exposure can offset much longer periods of visual
deprivation. This suggests that binocular exposure protects
against the effects of longer-term deprivation and is critical
to avoiding reverse amblyopia with longer periods of occlu-
sion therapy. Second, short daily periods of binocular
vision are important to restoring vision. The implication
here is that shorter periods of occlusion are likely to be just
as effective at recovering acuity and there is now evidence
from a multicentre RCT that supports this.16 Finally, they
discuss the remarkable finding that plunging a deprived
animal into total darkness for a period of up to 10 days
seems to reset the cortex to an earlier stage in development.
In this situation, no single eye is allowed to gain a competi-
tive advantage over the other and both rapidly develop acu-
ity to normal levels after being removed from the dark
environment. The importance of binocularity is continued
in work by Hess et al.,17 who emphasise the importance of
treating amblyopia as a binocular disorder. They argue that
in human amblyopia, the visual system maintains binocular
connections, but they are effectively masked by inter-ocular
suppression. In this view, removal of suppression is the key
to recovering vision. In support, a related paper by Raveen-
dran et al.18 shows that contrast-balancing and realigning
the input between eyes in strabismic amblyopes to reduce
suppression, results in better fixational stability. The need
to provide a balanced binocular input is further explored in
a paper by Ding & Levi.19 Their results indicate that where
it is possible to equate contrast between the eyes at a partic-
ular spatial scale, the suppressive balance is adjusted in
favour of the amblyopic eye. This raises the possibility that
rather than occlude one eye in favour of the other, a more
subtle manipulation of relative inputs to restore binocular-
ity might provide an effective treatment option.
This collection of papers touches upon some of the most
important aspects of this common neurological problem.
What is the aetiology and prevalence of amblyopia? Is
amblyopia a condition that is worth treating? If so, what
sort of treatment is most effective? Perhaps most impor-
tantly, what new knowledge has been generated and how
can this be exploited to develop alternative treatment
approaches? The key to remediating amblyopic visual loss
ultimately lies in gaining a better understanding of its neu-
ral basis. It seems likely that this will involve areas well
beyond the primary visual cortex and that understanding
binocular interactions in more detail will be essential.
Andrew T. Astle and Paul V. McGraw
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